Former Novartis India Chief Ranjit Shahani no more Ruchika Sharma11 March 2024 3:22 PM ISTNew Delhi: Former Vice Chairman and Managing Director of Novartis India and Chairman of JB Pharmaceuticals, Ranjit Shahani has passed...
Britain health regulator revokes conditional marketing authorisation for Novartis sickle cell drug Adakveo Ruchika Sharma22 Feb 2024 11:20 AM ISTSickle cell disease is a genetic disorder in which misshapen blood cells cause strokes, organ damage, severe pain and early death.
Will Novartis continue business in India? Global Drug major strategic review to decide Ruchika Sharma17 Feb 2024 2:16 PM ISTDrug major Novartis AG has announced a strategic review of Novartis India Ltd, a public company listed on the BSE.The strategic review will include an...
Novartis to acquire MorphoSys AG for EUR 68 per share or aggregate of EUR 2.7bn in cash Ruchika Sharma6 Feb 2024 12:30 PM ISTBasel: Novartis has announced that it has entered into an agreement to make a voluntary public takeover offer to acquire MorphoSys AG, a...
Novartis drops pursuit of Cytokinetics: Source Ruchika Sharma12 Jan 2024 4:00 PM ISTBasel: Swiss drugmaker Novartis has backed away from its pursuit of Cytokinetics, a person familiar with the matter told Reuters, and the...
Isomorphic Labs inks multi-target research collaboration with Novartis Ruchika Sharma12 Jan 2024 10:00 AM ISTLondon: Isomorphic Labs, a digital biology company has announced that it has entered into a strategic research collaboration with Novartis to...
Novartis in advanced talks to buy Cytokinetics: Source Ruchika Sharma10 Jan 2024 3:30 PM ISTAccess to Cytokinetics products would help Novartis offset the expected loss of U.S. exclusivity of Entresto, its key drug in this field, said...
Novartis expands production of Pluvicto with addition of its largest, most advanced radioligand therapy manufacturing facility in Indianapolis Ruchika Sharma7 Jan 2024 2:30 PM ISTBasel: Novartis has announced that it has received approval from the US Food and Drug Administration (FDA) for commercial manufacturing of...
Novartis Gets CDSCO Panel Nod to study Iptacopan Dr. Divya Colin23 Dec 2023 6:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Novartis, the Subject Expert Committee (SEC) functional under the Central Drug...
JB Pharma enters Opthalmology space, signs Rs 1,089 crore deal with Novartis for 10 brands Ruchika Sharma20 Dec 2023 11:14 AM ISTNew Delhi: JB Chemicals & Pharmaceuticals Ltd (JB Pharma) has announced that the Company has inked a trade mark licence agreement along with...
Novartis gets USFDA nod for Fabhalta for adults with paroxysmal nocturnal hemoglobinuria Ruchika Sharma7 Dec 2023 11:43 AM ISTBasel: Novartis has announced that the U.S. Food and Drug Administration (FDA) has approved Fabhalta (iptacopan) as the first oral monotherapy for the...
Novartis raises sales growth target to 5 percent a year through 2027 Ruchika Sharma28 Nov 2023 3:30 PM ISTFrankfurt: Novartis has dialled up its sales growth target to 5% per year until 2027, citing demand for innovative drugs after the spin off of...
